214 related articles for article (PubMed ID: 8649782)
21. JAC, a direct target of oncogenic transcription factor Jun, is involved in cell transformation and tumorigenesis.
Hartl M; Reiter F; Bader AG; Castellazzi M; Bister K
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13601-6. PubMed ID: 11698665
[TBL] [Abstract][Full Text] [Related]
22. Extracellular-regulated kinase 1/2, Jun N-terminal kinase, and c-Jun are involved in NF-kappa B-dependent IL-6 expression in human monocytes.
Tuyt LM; Dokter WH; Birkenkamp K; Koopmans SB; Lummen C; Kruijer W; Vellenga E
J Immunol; 1999 Apr; 162(8):4893-902. PubMed ID: 10202034
[TBL] [Abstract][Full Text] [Related]
23. Directed mutation of the basic domain of v-Jun alters DNA binding specificity and abolishes its oncogenic activity in chicken embryo fibroblasts.
Basso J; Briggs J; Findlay C; Bos T
Oncogene; 2000 Oct; 19(42):4876-85. PubMed ID: 11039905
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional control of SPARC by v-Jun and other members of the AP1 family of transcription factors.
Vial E; Perez S; Castellazzi M
Oncogene; 2000 Oct; 19(43):5020-9. PubMed ID: 11042689
[TBL] [Abstract][Full Text] [Related]
25. Stress-activated protein kinases bind directly to the delta domain of c-Jun in resting cells: implications for repression of c-Jun function.
Dai T; Rubie E; Franklin CC; Kraft A; Gillespie DA; Avruch J; Kyriakis JM; Woodgett JR
Oncogene; 1995 Mar; 10(5):849-55. PubMed ID: 7898927
[TBL] [Abstract][Full Text] [Related]
26. The fusion protein AML1-ETO in acute myeloid leukemia with translocation t(8;21) induces c-jun protein expression via the proximal AP-1 site of the c-jun promoter in an indirect, JNK-dependent manner.
Elsässer A; Franzen M; Kohlmann A; Weisser M; Schnittger S; Schoch C; Reddy VA; Burel S; Zhang DE; Ueffing M; Tenen DG; Hiddemann W; Behre G
Oncogene; 2003 Aug; 22(36):5646-57. PubMed ID: 12944913
[TBL] [Abstract][Full Text] [Related]
27. Characterization of Cd-induced molecular events prior to cellular damage in primary rat hepatocytes in culture: activation of the stress activated signal protein JNK and transcription factor AP-1.
Hsiao CJ; Stapleton SR
J Biochem Mol Toxicol; 2004; 18(3):133-42. PubMed ID: 15252869
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional activation by the v-Jun oncoprotein is independent of positive regulatory phosphorylation.
Black EJ; Catling AD; Woodgett JR; Kilbey A; Gillespie DA
Oncogene; 1994 Aug; 9(8):2363-8. PubMed ID: 8036019
[TBL] [Abstract][Full Text] [Related]
29. Amino acid substitutions modulate the effect of Jun on transformation, transcriptional activation and DNA replication.
Morgan IM; Asano M; Håvarstein LS; Ishikawa H; Hiiragi T; Ito Y; Vogt PK
Oncogene; 1993 May; 8(5):1135-40. PubMed ID: 8479738
[TBL] [Abstract][Full Text] [Related]
30. Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73.
Smeal T; Binetruy B; Mercola DA; Birrer M; Karin M
Nature; 1991 Dec; 354(6353):494-6. PubMed ID: 1749429
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade.
Kieser A; Kilger E; Gires O; Ueffing M; Kolch W; Hammerschmidt W
EMBO J; 1997 Nov; 16(21):6478-85. PubMed ID: 9351829
[TBL] [Abstract][Full Text] [Related]
32. Heterodimerization with c-Fos is not required for cell transformation of chicken embryo fibroblasts by Jun.
Hughes M; Sehgal A; Hadman M; Bos T
Cell Growth Differ; 1992 Dec; 3(12):889-97. PubMed ID: 1472469
[TBL] [Abstract][Full Text] [Related]
33. Mutation of a phosphorylation site in the DNA-binding domain is required for redox-independent transactivation of AP1-dependent genes by v-Jun.
Oehler T; Pintzas A; Stumm S; Darling A; Gillespie D; Angel P
Oncogene; 1993 May; 8(5):1141-7. PubMed ID: 8479739
[TBL] [Abstract][Full Text] [Related]
34. Microarray analysis identifies Autotaxin, a tumour cell motility and angiogenic factor with lysophospholipase D activity, as a specific target of cell transformation by v-Jun.
Black EJ; Clair T; Delrow J; Neiman P; Gillespie DA
Oncogene; 2004 Mar; 23(13):2357-66. PubMed ID: 14691447
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of avian or mouse c-jun in primary chick embryo fibroblasts confers a partially transformed phenotype.
Castellazzi M; Dangy JP; Mechta F; Hirai S; Yaniv M; Samarut J; Lassailly A; Brun G
Oncogene; 1990 Oct; 5(10):1541-7. PubMed ID: 2123532
[TBL] [Abstract][Full Text] [Related]
36. AP-1 activity during normal human keratinocyte differentiation: evidence for a cytosolic modulator of AP-1/DNA binding.
Briata P; D'Anna F; Franzi AT; Gherzi R
Exp Cell Res; 1993 Jan; 204(1):136-46. PubMed ID: 8416791
[TBL] [Abstract][Full Text] [Related]
37. Glycogen synthase kinase 3 phosphorylates Jun family members in vitro and negatively regulates their transactivating potential in intact cells.
Nikolakaki E; Coffer PJ; Hemelsoet R; Woodgett JR; Defize LH
Oncogene; 1993 Apr; 8(4):833-40. PubMed ID: 8384354
[TBL] [Abstract][Full Text] [Related]
38. Tyrosine 170 is dispensable for c-Jun turnover.
Xie M; Sabapathy K
Cell Signal; 2010 Feb; 22(2):330-7. PubMed ID: 19818398
[TBL] [Abstract][Full Text] [Related]
39. The evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents stress-induced cell death.
Kurokawa M; Mitani K; Yamagata T; Takahashi T; Izutsu K; Ogawa S; Moriguchi T; Nishida E; Yazaki Y; Hirai H
EMBO J; 2000 Jun; 19(12):2958-68. PubMed ID: 10856240
[TBL] [Abstract][Full Text] [Related]
40. An oncogenic mutation uncouples the v-Jun oncoprotein from positive regulation by the SAPK/JNK pathway in vivo.
May GH; Funk M; Black EJ; Clark W; Hussain S; Woodgett JR; Gillespie DA
Curr Biol; 1998 Jan; 8(2):117-20. PubMed ID: 9427647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
